Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antti Cajanus

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Neuroscience|July 12, 2019
Prodromal and Early bvFTD: Evaluating Clinical Features and Current BiomarkersKasper Katisko, Antti Cajanus, Titta Korhonen, et al.
Journal of Neurology|April 4, 2022
Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementiaSami Heikkinen, Antti Cajanus, Kasper Katisko, et al.
Dementia and Geriatric Cognitive Disorders|June 3, 2020
Comparison of Prodromal Symptoms of Patients with Behavioral Variant Frontotemporal Dementia and Alzheimer DiseaseTitta Korhonen, Kasper Katisko, Antti Cajanus, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Frontiers in Neuroscience|June 4, 2019
Astrocytes and Microglia as Potential Contributors to the Pathogenesis of <i>C9orf72</i> Repeat Expansion-Associated FTLD and ALSHannah Rostalski, Stina Leskelä, Nadine Huber, et al.
Annals of Clinical and Translational Neurology|May 23, 2020
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosisAntti Cajanus, Kasper Katisko, Aleksi Kontkanen, et al.
Journal of Neurology|October 10, 2019
Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disordersKasper Katisko, Antti Cajanus, Olli Jääskeläinen, et al.
Frontiers in Neurology|October 22, 2019
The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal DementiaAntti Cajanus, Eino Solje, Juha Koikkalainen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performanceKasper Katisko, Antti Cajanus, Nadine Huber, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 3, 2018
Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia DiagnosisAntti Cajanus, Anette Hall, Juha Koikkalainen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Neuroscience|July 12, 2019
Prodromal and Early bvFTD: Evaluating Clinical Features and Current BiomarkersKasper Katisko, Antti Cajanus, Titta Korhonen, et al.
Journal of Neurology|April 4, 2022
Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementiaSami Heikkinen, Antti Cajanus, Kasper Katisko, et al.
Dementia and Geriatric Cognitive Disorders|June 3, 2020
Comparison of Prodromal Symptoms of Patients with Behavioral Variant Frontotemporal Dementia and Alzheimer DiseaseTitta Korhonen, Kasper Katisko, Antti Cajanus, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Frontiers in Neuroscience|June 4, 2019
Astrocytes and Microglia as Potential Contributors to the Pathogenesis of <i>C9orf72</i> Repeat Expansion-Associated FTLD and ALSHannah Rostalski, Stina Leskelä, Nadine Huber, et al.
Annals of Clinical and Translational Neurology|May 23, 2020
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosisAntti Cajanus, Kasper Katisko, Aleksi Kontkanen, et al.
Journal of Neurology|October 10, 2019
Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disordersKasper Katisko, Antti Cajanus, Olli Jääskeläinen, et al.
Frontiers in Neurology|October 22, 2019
The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal DementiaAntti Cajanus, Eino Solje, Juha Koikkalainen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performanceKasper Katisko, Antti Cajanus, Nadine Huber, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 3, 2018
Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia DiagnosisAntti Cajanus, Anette Hall, Juha Koikkalainen, et al.
Pageof 1